FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 340:609-616 February 25, 1999 Number 8 Next

	Full Text PDF Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article PubMed Citation

ABSTRACT

Background Population-based studies have found that black patients with congestive heart failure have a higher mortality rate than white patients with the same condition. This finding has been attributed to differences in the severity, causes, and management of heart failure, the prevalence of coexisting conditions, and socioeconomic factors. Although these factors probably account for some of the higher mortality due to congestive heart failure among blacks, we hypothesized that racial differences in the natural history of left ventricular dysfunction might also have a role.

Methods Using data from the Studies of Left Ventricular Dysfunction (SOLVD) prevention and treatment trials, in which all patients received standardized therapy and follow-up, we conducted a retrospective analysis of the outcomes of asymptomatic and symptomatic left ventricular systolic dysfunction among black and white participants. The mean (±SD) follow-up was 34.2±14.0 months in the prevention trial and 32.3±14.8 months in the treatment trial among the black and white participants.

Results The overall mortality rates in the prevention trial were 8.1 per 100 person-years for blacks and 5.1 per 100 person years for whites. In the treatment trial, the rates were 16.7 per 100 person-years and 13.4 per 100 person-years, respectively. After adjustment for age, coexisting conditions, severity and causes of heart failure, and use of medications, blacks had a higher risk of death from all causes in both the SOLVD prevention trial (relative risk, 1.36; 95 percent confidence interval, 1.06 to 1.74; P=0.02) and the treatment trial (relative risk, 1.25; 95 percent confidence interval, 1.04 to 1.50; P=0.02). In both trials blacks were also at higher risk for death due to pump failure and for the combined end point of death from any cause or hospitalization for heart failure, our two predefined indicators of the progression of left ventricular systolic dysfunction.

Conclusions Blacks with mild-to-moderate left ventricular systolic dysfunction appear to be at higher risk for progression of heart failure and death from any cause than similarly treated whites. These results suggest that there may be racial differences in the outcome of asymptomatic and symptomatic left ventricular systolic dysfunction.

Source Information

From the Clinical Trials Scientific Research Group, Division of Epidemiology and Clinical Application, National Heart, Lung, and Blood Institute, Bethesda, Md. (D.L.D., D.V.E., H.A.C., M.J.D.); the Division of Cardiology, Georgetown University Hospital, Washington, D.C. (B.J.G.); and the Department of Veterans Affairs, Washington, D.C. (P.E.C.).

Address reprint requests to Dr. Dries at Clinical Trials Scientific Research Group, NHLBI, 2 Rockledge Ctr., 6701 Rockledge Dr., Rm. 8149, Bethesda, MD 20892-7936, or at ddries{at}aol.com.

Full Text of this Article

Related Letters:

Racial Differences in the Outcome of Left Ventricular Dysfunction
Stolley P. D., Saha S., Hebbar S., Dries D. L., Exner D. V., Domanski M. J.
Extract | Full Text  
N Engl J Med 1999; 341:287-288, Jul 22, 1999. Correspondence

This article has been cited by other articles:

• Henderson, G. E. (2008). Introducing Social and Ethical Perspectives on Gene--Environment Research. Sociological Methods Research 37: 251-276 [Abstract]  
• Bahrami, H., Kronmal, R., Bluemke, D. A., Olson, J., Shea, S., Liu, K., Burke, G. L., Lima, J. A. C. (2008). Differences in the Incidence of Congestive Heart Failure by Ethnicity: The Multi-Ethnic Study of Atherosclerosis. Arch Intern Med 168: 2138-2145 [Abstract] [Full Text]  
• Piccini, J. P., Hernandez, A. F., Dai, D., Thomas, K. L., Lewis, W. R., Yancy, C. W., Peterson, E. D., Fonarow, G. C., for the Get With the Guidelines Steering Committee, (2008). Use of Cardiac Resynchronization Therapy in Patients Hospitalized With Heart Failure. Circulation 118: 926-933 [Abstract] [Full Text]  
• Kamath, S. A., Drazner, M. H., Wynne, J., Fonarow, G. C., Yancy, C. W. (2008). Characteristics and Outcomes in African American Patients With Decompensated Heart Failure. Arch Intern Med 168: 1152-1158 [Abstract] [Full Text]  
• Prisant, L. M., Thomas, K. L., Lewis, E. F., Huang, Z., Francis, G. S., Weaver, W. D., Pfeffer, M. A., McMurray, J. J.V., Califf, R. M., Velazquez, E. J. (2008). Racial Analysis of Patients With Myocardial Infarction Complicated by Heart Failure and/or Left Ventricular Dysfunction Treated With Valsartan, Captopril, or Both. J Am Coll Cardiol 51: 1865-1871 [Abstract] [Full Text]  
• Yancy, C. W., Abraham, W. T., Albert, N. M., Clare, R., Stough, W. G., Gheorghiade, M., Greenberg, B. H., O'Connor, C. M., She, L., Sun, J. L., Young, J. B., Fonarow, G. C. (2008). Quality of Care of and Outcomes for African Americans Hospitalized With Heart Failure: Findings From the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients With Heart Failure) Registry. J Am Coll Cardiol 51: 1675-1684 [Abstract] [Full Text]  
• Damasceno, A., Cotter, G., Dzudie, A., Sliwa, K., Mayosi, B. M. (2007). Heart Failure in Sub-Saharan Africa: Time for Action. J Am Coll Cardiol 50: 1688-1693 [Full Text]  
• Davis, A. M., Vinci, L. M., Okwuosa, T. M., Chase, A. R., Huang, E. S. (2007). Cardiovascular Health Disparities: A Systematic Review of Health Care Interventions. Med Care Res Rev 64: 29S-100S [Abstract]  
• Bibbins-Domingo, K., Fernandez, A. (2007). BiDil for Heart Failure in Black Patients: Implications of the U.S. Food and Drug Administration Approval. ANN INTERN MED 146: 52-56 [Abstract] [Full Text]  
• Taylor, A. L., Lindenfeld, J., Ziesche, S., Walsh, M. N., Mitchell, J. E., Adams, K., Tam, S. W., Ofili, E., Sabolinski, M. L., Worcel, M., Cohn, J. N., for the A-HeFT Investigators, (2006). Outcomes by Gender in the African-American Heart Failure Trial. J Am Coll Cardiol 48: 2263-2267 [Abstract] [Full Text]  
• Puckrein, G. (2006). BiDil: From Another Vantage Point. Health Aff (Millwood) 25: w368-w374 [Abstract] [Full Text]  
• Heflin, M. T., Pollak, K. I., Kuchibhatla, M. N., Branch, L. G., Oddone, E. Z. (2006). The impact of health status on physicians' intentions to offer cancer screening to older women.. J. Gerontol. A Biol. Sci. Med. Sci. 61: 844-850 [Abstract] [Full Text]  
• Bibbins-Domingo, K., Chertow, G. M., Fried, L. F., Odden, M. C., Newman, A. B., Kritchevsky, S. B., Harris, T. B., Satterfield, S., Cummings, S. R., Shlipak, M. G. (2006). Renal function and heart failure risk in older black and white individuals: the health, aging, and body composition study.. Arch Intern Med 166: 1396-1402 [Abstract] [Full Text]  
• Vivian, E. M (2006). Should Drug Therapy Be Personalized Based on Race?. The Annals of Pharmacotherapy 40: 550-552 [Abstract] [Full Text]  
• Angus, D. C., Linde-Zwirble, W. T., Tam, S. W., Ghali, J. K., Sabolinski, M. L., Villagra, V. G., Winkelmayer, W. C., Worcel, M., for the African-American Heart Failure Trial (A-He, (2005). Cost-Effectiveness of Fixed-Dose Combination of Isosorbide Dinitrate and Hydralazine Therapy for Blacks With Heart Failure. Circulation 112: 3745-3753 [Abstract] [Full Text]  
• Barr, D. A. (2005). The Practitioner's Dilemma: Can We Use a Patient's Race To Predict Genetics, Ancestry, and the Expected Outcomes of Treatment?. ANN INTERN MED 143: 809-815 [Abstract] [Full Text]  
• Newton, J D, Blackledge, H M, Squire, I B (2005). Ethnicity and variation in prognosis for patients newly hospitalised for heart failure: a matched historical cohort study. Heart 91: 1545-1550 [Abstract] [Full Text]  
• Verderese, C. (2005). Drug for Black Patients With Heart Failure Nears Approval. DOC News 2: 1-8 [Full Text]  
• Smith, G. L., Shlipak, M. G., Havranek, E. P., Masoudi, F. A., McClellan, W. M., Foody, J. M., Rathore, S. S., Krumholz, H. M. (2005). Race and Renal Impairment in Heart Failure: Mortality in Blacks Versus Whites. Circulation 111: 1270-1277 [Abstract] [Full Text]  
• Moran, A. E., Cooper, R. S., Fitzgibbons, T. P., Chow, A. Y., Bellin, E. Y., Eisenberger, A. B., Taylor, A. L., Cohn, J., Worcel, M. (2005). Isosorbide dinitrate and hydralazine in blacks with heart failure.. NEJM 352: 1041-1043 [Full Text]  
• Ripley, T. L (2005). Valsartan in Chronic Heart Failure. The Annals of Pharmacotherapy 39: 460-469 [Abstract] [Full Text]  
• Taylor, A. L., Ziesche, S., Yancy, C., Carson, P., D'Agostino, R. Jr., Ferdinand, K., Taylor, M., Adams, K., Sabolinski, M., Worcel, M., Cohn, J. N., the African-American Heart Failure Trial Investiga, (2004). Combination of Isosorbide Dinitrate and Hydralazine in Blacks with Heart Failure. NEJM 351: 2049-2057 [Abstract] [Full Text]  
• Barnes, L. L., De Leon, C. F. M., Wilson, R. S., Bienias, J. L., Bennett, D. A., Evans, D. A. (2004). Racial Differences in Perceived Discrimination in a Community Population of Older Blacks and Whites. J Aging Health 16: 315-337 [Abstract]  
• Deswal, A., Petersen, N. J., Souchek, J., Ashton, C. M., Wray, N. P. (2004). Impact of race on health care utilization and outcomes in veterans with congestive heart failure. J Am Coll Cardiol 43: 778-784 [Abstract] [Full Text]  
• Sackner-Bernstein, J. D., Skopicki, H. A. (2004). Racing away from bias. J Am Coll Cardiol 43: 785-786 [Full Text]  
• Ibrahim, S. A., Thomas, S. B., Fine, M. J. (2003). Achieving Health Equity: An Incremental Journey. Am. J. Public Health 93: 1619-1621 [Full Text]  
• Blackledge, H. M, Newton, J., Squire, I. B (2003). Prognosis for South Asian and white patients newly admitted to hospital with heart failure in the United Kingdom: historical cohort study. BMJ 327: 526-531 [Abstract] [Full Text]  
• Houghton, J. L., Strogatz, D. S., Torosoff, M. T., Smith, V. E., Fein, S. A., Kuhner, P. A., Philbin, E. F., Carr, A. A. (2003). African Americans With LVH Demonstrate Depressed Sensitivity of the Coronary Microcirculation to Stimulated Relaxation. Hypertension 42: 269-276 [Abstract] [Full Text]  
• Rathore, S. S., Foody, J. M., Wang, Y., Smith, G. L., Herrin, J., Masoudi, F. A., Wolfe, P., Havranek, E. P., Ordin, D. L., Krumholz, H. M. (2003). Race, Quality of Care, and Outcomes of Elderly Patients Hospitalized With Heart Failure. JAMA 289: 2517-2524 [Abstract] [Full Text]  
• Volpe, M., Savoia, C., De Paolis, P., Ostrowska, B., Tarasi, D., Rubattu, S. (2002). The Renin-Angiotensin System as a Risk Factor and Therapeutic Target for Cardiovascular and Renal Disease. J. Am. Soc. Nephrol. 13: S173-178 [Abstract] [Full Text]  
• Hajjar, R. J., MacRae, C. A. (2002). Adrenergic-Receptor Polymorphisms and Heart Failure. NEJM 347: 1196-1199 [Full Text]  
• Dries, D. L., Strong, M. H., Cooper, R. S., Drazner, M. H. (2002). Efficacy of angiotensin-converting enzyme inhibition in reducing progression from asymptomatic left ventricular dysfunction to symptomatic heart failure in black and white patients. J Am Coll Cardiol 40: 311-317 [Abstract] [Full Text]  
• Devereux, R. B., Bella, J. N., Palmieri, V., Oberman, A., Kitzman, D. W., Hopkins, P. N., Rao, D.C., Morgan, D., Paranicas, M., Fishman, D., Arnett, D. K. (2001). Left Ventricular Systolic Dysfunction in a Biracial Sample of Hypertensive Adults: The HyperGEN Study. Hypertension 38: 417-423 [Abstract] [Full Text]  
• Drazner, M. H., Rame, J. E., Stevenson, L. W., Dries, D. L. (2001). Prognostic Importance of Elevated Jugular Venous Pressure and a Third Heart Sound in Patients with Heart Failure. NEJM 345: 574-581 [Abstract] [Full Text]  
• Ibrahim, S. A., Cook, C. F., Kwoh, C. K., Rosenthal, G. E., Snow, R. J., Harper, D. L., Baker, D. W. (2001). Racial Differences in Mortality among Elderly Patients Admitted for Heart Failure. Research on Aging 23: 457-472 [Abstract]  
• The Beta-Blocker Evaluation of Survival Trial Inve, (2001). A Trial of the Beta-Blocker Bucindolol in Patients with Advanced Chronic Heart Failure. NEJM 344: 1659-1667 [Abstract] [Full Text]  
• Exner, D. V., Dries, D. L., Domanski, M. J., Cohn, J. N. (2001). Lesser Response to Angiotensin-Converting-Enzyme Inhibitor Therapy in Black as Compared with White Patients with Left Ventricular Dysfunction. NEJM 344: 1351-1357 [Abstract] [Full Text]  
• Yancy, C. W., Fowler, M. B., Colucci, W. S., Gilbert, E. M., Bristow, M. R., Cohn, J. N., Lukas, M. A., Young, S. T., Packer, M., the U.S. Carvedilol Heart Failure Study Group, (2001). Race and the Response to Adrenergic Blockade with Carvedilol in Patients with Chronic Heart Failure. NEJM 344: 1358-1365 [Abstract] [Full Text]  
• Deswal, A., Petersen, N. J., Feldman, A. M., Young, J. B., White, B. G., Mann, D. L. (2001). Cytokines and Cytokine Receptors in Advanced Heart Failure : An Analysis of the Cytokine Database from the Vesnarinone Trial (VEST). Circulation 103: 2055-2059 [Abstract] [Full Text]  
• Jha, A. K., Shlipak, M. G., Hosmer, W., Frances, C. D., Browner, W. S. (2001). Racial Differences in Mortality Among Men Hospitalized in the Veterans Affairs Health Care System. JAMA 285: 297-303 [Abstract] [Full Text]  
• Berniker, J. S. (2000). Legal Implications of Discrimination in Medical Practice. J Law Med Ethics 28: 85-87  
• Gibbs, C.R., Lip, G.Y.H. (1999). Letters to the Editor: Ethnicity and heart failure. Eur Heart J 20: 1436-1437  
• Stolley, P. D., Saha, S., Hebbar, S., Dries, D. L., Exner, D. V., Domanski, M. J. (1999). Racial Differences in the Outcome of Left Ventricular Dysfunction. NEJM 341: 287-288 [Full Text]  
• (1999). Racial Differences and Prognosis with LV Dysfunction. Journal Watch Cardiology 1999: 1-1 [Full Text]